Blood Banking (Virucidal)

Agreement Signed for Methylene Blue Technology

Published in Blood Weekly, April 1st, 1996

HemaSure Inc., Marlborough, Massachusetts, announced that it has entered into a definitive cooperation agreement with the German Red Cross (DRK), Springe, Germany, to broaden the worldwide use of methylene blue technology to produce safer transfusion plasma.

Under the agreement, HemaSure is a licensing agent for DRK's patented methylene blue technology for the inactivation of lipid-enveloped viruses in transfusion plasma. The agreement grants DRK an option to enter into a separate contract for the purchase and sale of HemaSure's LeukoVir-MB Filter, designed to remove methylene blue and leukocytes from transfusion plasma.

"Methylene blue technology...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1996-04-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry